These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

144 related items for PubMed ID: 8161347

  • 41.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 42.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 43. Decrease in hepatic microsomal UDP-glucuronosyl-transferase activity in rats and cattle with fascioliasis: impaired in vitro glucuronidation of oxyclozanide.
    Maffei Facino R, Carini M, Genchi C.
    Toxicol Lett; 1985 Jul; 26(1):65-71. PubMed ID: 3927525
    [Abstract] [Full Text] [Related]

  • 44.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 45.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 46.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 47. p-Nitrophenol glucuronidation in bile duct ligated rats.
    Ouviña GB, Lemberg A, Bengochea LA.
    Arch Int Physiol Biochim Biophys; 1993 Jul; 101(1):77-8. PubMed ID: 7684283
    [Abstract] [Full Text] [Related]

  • 48. A kinetic mechanism for modulation of the activity of microsomal UDP-glucuronyltransferase by phospholipids. Effects of lysophosphatidylcholines.
    Hochman Y, Zakim D, Vessey DA.
    J Biol Chem; 1981 May 25; 256(10):4783-8. PubMed ID: 6785274
    [Abstract] [Full Text] [Related]

  • 49. Inhibition and activation of UDP-glucuronyltransferase in alloxanic-diabetic rats.
    Vega P, Gaule C, Sanchez E, del Villar E.
    Gen Pharmacol; 1986 May 25; 17(6):641-5. PubMed ID: 3102313
    [Abstract] [Full Text] [Related]

  • 50.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 51.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 52.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 53.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 54.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 55.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 56.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 57.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 58. The influence of fatty acid unsaturation and physical properties of microsomal membrane phospholipids on UDP-glucuronyltransferase activity.
    Castuma CE, Brenner RR.
    Biochem J; 1989 Mar 15; 258(3):723-31. PubMed ID: 2499306
    [Abstract] [Full Text] [Related]

  • 59. Inhibition of UDP-glucuronosyltransferase activity by possible transition-state analogues in rat-liver microsomes.
    Noort D, Coughtrie MW, Burchell B, van der Marel GA, van Boom JH, van der Gen A, Mulder GJ.
    Eur J Biochem; 1990 Mar 10; 188(2):309-12. PubMed ID: 2108023
    [Abstract] [Full Text] [Related]

  • 60. Latency is the major determinant of UDP-glucuronosyltransferase activity in isolated hepatocytes.
    Bánhegyi G, Garzó T, Fulceri R, Benedetti A, Mandl J.
    FEBS Lett; 1993 Aug 09; 328(1-2):149-52. PubMed ID: 8393805
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 8.